1h Free Analyst Time
The ibuprofen active pharmaceutical ingredient (API) market is forecasted to grow by USD 27.38 million during 2024-2029, accelerating at a CAGR of 2.1% during the forecast period. The report on the ibuprofen active pharmaceutical ingredient (API) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing geriatric population, evolving api manufacturing scenario in developing countries, and increase in pharmaceutical and biopharmaceutical production.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The ibuprofen active pharmaceutical ingredient (API) market is segmented as below:
By End-user
- Pharmaceutical
- Contract manufacturing organizations
By Product
- Prescription
- Over-the-counter
By Geographical Landscape
- Asia
- North America
- Europe
- Rest of World (ROW)
The report on the ibuprofen active pharmaceutical ingredient (API) market covers the following areas:
- Ibuprofen Active Pharmaceutical Ingredient (API) Market sizing
- Ibuprofen Active Pharmaceutical Ingredient (API) Market forecast
- Ibuprofen Active Pharmaceutical Ingredient (API) Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by End-user
9 Market Segmentation by Product
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global ibuprofen active pharmaceutical ingredient (API) market: Arch Pharmalabs Ltd., Athos Chemicals Pvt. Ltd., Azelis SA, BASF SE, Chemino Pharma Ltd., DR Reddys Laboratories Ltd., Granules India Ltd., HELM AG, IOL Chemicals and Pharmaceuticals Ltd., Mallinckrodt PLC, Octavius Pharma Pvt. Ltd., Otto Brandes GmbH, Piramal Enterprises Ltd., Rochem International Inc., SI Group Inc., Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd., Solara Active Pharma Sciences Ltd, Strides Pharma Science Ltd., Teva Pharmaceutical Industries Ltd., and Titan LAB Pvt Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is paradigm shift in API manufacturing."
According to the report, one of the major drivers for this market is the increasing geriatric population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Arch Pharmalabs Ltd.
- Athos Chemicals Pvt. Ltd.
- Azelis SA
- BASF SE
- Chemino Pharma Ltd.
- Dr Reddys Laboratories Ltd.
- Granules India Ltd.
- HELM AG
- IOL Chemicals and Pharmaceuticals Ltd.
- Mallinckrodt Plc
- Octavius Pharma Pvt. Ltd.
- Otto Brandes GmbH
- Piramal Enterprises Ltd.
- Rochem International Inc.
- SI Group Inc.
- Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd.
- Solara Active Pharma Sciences Ltd
- Strides Pharma Science Ltd.
- Teva Pharmaceutical Industries Ltd.
- Titan Lab Pvt Ltd.
